Mahamaya Lifesc.

Why is Mahamaya Lifesciences Ltd falling/rising?

As of 31-Aug, Mahamaya Lifesciences Ltd's stock price is rising to 185.50, reflecting a 2.06% increase after a trend reversal and strong initial buying interest. The stock outperformed its sector and remains liquid for trading despite a recent drop in delivery volume.

As of 31-Aug, Mahamaya Lifesciences Ltd's stock price is rising, currently at 185.50, which reflects an increase of 3.75 or 2.06%. This upward movement can be attributed to several factors. Firstly, the stock has shown a trend reversal, gaining after four consecutive days of decline. Additionally, it opened with a significant gap up of 2.86% today, indicating strong initial buying interest. The stock also reached an intraday high of Rs 187.9, which is a 3.38% increase from the previous close.<BR><BR>Moreover, the stock has outperformed its sector by 3.59%, suggesting that it is gaining traction relative to its peers. Despite a recent decline in investor participation, as evidenced by a 95.93% drop in delivery volume on August 28 compared to the 5-day average, the stock remains liquid enough for trading. It is also trading above its 20-day, 50-day, 100-day, and 200-day moving averages, which typically indicates a positive trend. Overall, these factors contribute to the current rise in Mahamaya Lifesciences Ltd's stock price.

What does Mahamaya Lifesc. do?

Mahamaya Lifesciences Ltd operates in the pesticides and agrochemicals sector as a micro-cap company, having transitioned to a public limited company in 2024. Key financial metrics include a market cap of INR 438 Cr, a P/E ratio of 26, and a return on equity of 13.63%.

Overview: <BR>Mahamaya Lifesciences Ltd operates in the pesticides and agrochemicals industry and is classified as a micro-cap company.<BR><BR>History: <BR>Mahamaya Lifesciences Ltd was originally incorporated as "Mahamaya Life Sciences Private Limited" in 2002. The company changed its name to "Mahamaya Lifesciences Private Limited" on February 15, 2016, and transitioned to a public limited company on November 19, 2024. Revenue and profit data for the latest quarter are not available.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: N/A <BR>Market-cap value: INR 438 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 26.00 <BR>Industry P/E: 26 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.42 <BR>Return on Equity: 13.63% <BR>Price-to-Book: 3.47 <BR><BR>Contact Details: <BR>Address: Not available <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

Who are the peers of the Mahamaya Lifesc.?

Mahamaya Lifesc.'s peers include Dharmaj Crop, Heranba Inds, Best Agrolife, Shivalik Rasayan, Super Crop Safe, Bhaskar Agrochem, Crop Life Science, Aristo Bio-Tech, and Dhansa Labs, with varying management risks and growth rates. Super Crop Safe has the highest 1-year return at 23.78%, while Heranba Inds has the lowest at -51.21%.

Peers: The peers of Mahamaya Lifesc. are Dharmaj Crop, Heranba Inds, Best Agrolife, Shivalik Rasayan, Super Crop Safe, Bhaskar Agrochem, Crop Life Scienc, Aristo Bio-Tech, and Dhansa Labs.<BR><BR>Quality Snapshot: Excellent management risk is observed at Shivalik Rasayan and Best Agrolife, while Average management risk is found at Dharmaj Crop, Crop Life Scienc, Aristo Bio-Tech, and Heranba Inds. Good management risk is noted for Bhaskar Agrochem, while Below Average management risk is seen at Super Crop Safe, Dhansa Labs, and the rest. In terms of Growth, Good growth is seen at Dharmaj Crop, while Below Average growth is found at Heranba Inds, Best Agrolife, Bhaskar Agrochem, Super Crop Safe, Crop Life Scienc, and the rest. Average growth is noted at Aristo Bio-Tech, while Shivalik Rasayan has Below Average growth. For Capital Structure, Excellent capital structure is observed at Shivalik Rasayan, while Good capital structure is noted for Dharmaj Crop and Average capital structure is found at Best Agrolife, Aristo Bio-Tech, and the rest. Below Average capital structure is seen at Heranba Inds, Super Crop Safe, Bhaskar Agrochem, Crop Life Scienc, and Dhansa Labs.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Super Crop Safe at 23.78%, while the peer with the lowest is Heranba Inds at -51.21%. Mahamaya Lifesc.'s 1-year return is not available for comparison. Additionally, peers with negative six-month returns include Heranba Inds, Bhaskar Agrochem, and Dhansa Labs.

How big is Mahamaya Lifesc.?

As of 31st August, Mahamaya Lifesciences Ltd has a market capitalization of 438.00 Cr, classifying it as a Micro Cap company. There is no valid financial data available for Net Sales and Net Profit for the latest four quarters.

As of 31st August, <BR><BR>Market Cap: Mahamaya Lifesciences Ltd has a market capitalization of 438.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for Net Sales and Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2025, with Shareholder's Funds amounting to 49.42 Cr and Total Assets valued at 188.35 Cr.

Which are the latest news on Mahamaya Lifesc.?

When is the next results date for Mahamaya Lifesciences Ltd?

The next results date for Mahamaya Lifesciences Ltd is 25 May 2026.

The next results date for Mahamaya Lifesciences Ltd is scheduled for 25 May 2026.